检验医学
檢驗醫學
검험의학
LABORATORY MEDICINE
2014年
4期
331-336
,共6页
纤维结合蛋白%肝纤维化%肝硬化%总胆汁酸%白蛋白
纖維結閤蛋白%肝纖維化%肝硬化%總膽汁痠%白蛋白
섬유결합단백%간섬유화%간경화%총담즙산%백단백
Fibronectin%Hepatofibrosis%Cirrhosis%Total bile acid%Albumin
目的:探讨肝病患者血清纤维结合蛋白(Fn)含量变化及其在肝纤维化中的意义。方法测定肝病组以及正常对照组血清Fn含量,同时测定血清总胆汁酸(TBA)、白蛋白(Alb)进行比较分析。结果急性肝炎组和肝癌组血清Fn与正常对照组差异无统计学意义(P>0.05);慢性肝炎中度、重度及肝硬化失代偿期组血清Fn含量均降低,与正常对照组差异有统计学意义(P<0.05)。肝硬化失代偿组较其它肝病组血清Fn含量明显降低(P<0.05);酒精性肝硬化与病毒性肝硬化组血清Fn含量差异无统计学意义(P>0.05);肝硬化失代偿合并腹膜炎、消化道出血、脾功能亢进等并发症组血清Fn较无并发症组明显降低(P<0.05)。正常对照组、急性肝炎组、肝癌组血清Fn与TBA无相关性(P>0.05),慢性肝炎中度、重度及肝硬化失代偿组血清Fn与TBA呈负相关(r=-0.593、-0.677、-0.714,P<0.05);各组血清Fn与Alb无相关性(P>0.05)。结论血清Fn在一定程度上可反映肝细胞的功能,对于肝纤维化,尤其是肝硬化、肝硬化合并感染的诊断有一定的参考价值。Fn和TBA、Alb联合检测可明显提高肝纤维化诊断的准确性和可靠性。
目的:探討肝病患者血清纖維結閤蛋白(Fn)含量變化及其在肝纖維化中的意義。方法測定肝病組以及正常對照組血清Fn含量,同時測定血清總膽汁痠(TBA)、白蛋白(Alb)進行比較分析。結果急性肝炎組和肝癌組血清Fn與正常對照組差異無統計學意義(P>0.05);慢性肝炎中度、重度及肝硬化失代償期組血清Fn含量均降低,與正常對照組差異有統計學意義(P<0.05)。肝硬化失代償組較其它肝病組血清Fn含量明顯降低(P<0.05);酒精性肝硬化與病毒性肝硬化組血清Fn含量差異無統計學意義(P>0.05);肝硬化失代償閤併腹膜炎、消化道齣血、脾功能亢進等併髮癥組血清Fn較無併髮癥組明顯降低(P<0.05)。正常對照組、急性肝炎組、肝癌組血清Fn與TBA無相關性(P>0.05),慢性肝炎中度、重度及肝硬化失代償組血清Fn與TBA呈負相關(r=-0.593、-0.677、-0.714,P<0.05);各組血清Fn與Alb無相關性(P>0.05)。結論血清Fn在一定程度上可反映肝細胞的功能,對于肝纖維化,尤其是肝硬化、肝硬化閤併感染的診斷有一定的參攷價值。Fn和TBA、Alb聯閤檢測可明顯提高肝纖維化診斷的準確性和可靠性。
목적:탐토간병환자혈청섬유결합단백(Fn)함량변화급기재간섬유화중적의의。방법측정간병조이급정상대조조혈청Fn함량,동시측정혈청총담즙산(TBA)、백단백(Alb)진행비교분석。결과급성간염조화간암조혈청Fn여정상대조조차이무통계학의의(P>0.05);만성간염중도、중도급간경화실대상기조혈청Fn함량균강저,여정상대조조차이유통계학의의(P<0.05)。간경화실대상조교기타간병조혈청Fn함량명현강저(P<0.05);주정성간경화여병독성간경화조혈청Fn함량차이무통계학의의(P>0.05);간경화실대상합병복막염、소화도출혈、비공능항진등병발증조혈청Fn교무병발증조명현강저(P<0.05)。정상대조조、급성간염조、간암조혈청Fn여TBA무상관성(P>0.05),만성간염중도、중도급간경화실대상조혈청Fn여TBA정부상관(r=-0.593、-0.677、-0.714,P<0.05);각조혈청Fn여Alb무상관성(P>0.05)。결론혈청Fn재일정정도상가반영간세포적공능,대우간섬유화,우기시간경화、간경화합병감염적진단유일정적삼고개치。Fn화TBA、Alb연합검측가명현제고간섬유화진단적준학성화가고성。
Objective To investigate the change of serum fibronectin (Fn)level in patients with hepatopathy and the significance of Fn in hepatofibrosis.Methods Serum Fn levels in patients with hepatopathy and healthy controls were determined.Serum total bile acid (TBA)and albumin (Alb)were determined,and the results were analyzed comparatively.Results Serum Fn levels in patients with oxyhepatitis and liver cancer had no statistical significance with those in healthy controls with statistical significance (P>0.05).Serum Fn levels in patients with chronic moderate hepatitis,chronic severe hepatitis and cirrhosis were lower than those in healthy controls with statistical significance (P<0.05).Serum Fn levels in patients with cirrhosis were lower than those in other patients with hepatopathy (P<0.05).Serum Fn levels in patients with alcohol cirrhosis and virus cirrhosis had no statistical significance (P>0.05). Serum Fn levels in cirrhosis patients with complications,such as peritonitis, hemorrhage of digestive tract and hypersplenia,decreased significantly than those without complications (P<0.05 ).Serum Fn and TBA in healthy controls and patients with oxyhepatitis and liver cancer had no correlation (P>0.05 ),and had negative correlation between patients with chronic moderate hepatitis,chronic severe hepatitis and cirrhosis (r=-0.593,-0.677 and-0.71 4,P<0.05 ).Serum Fn had no correlation with Alb (P>0.05 ).Conclusions Serum Fn can reflect the function of hepatocyte in a certain extent,and has certain reference significance in the diagnosis of hepatofibrosis especially cirrhosis and cirrhosis with infection.The diagnostic accuracy and reliability of Fn determination with TBA and Alb can be obviously improved.